Annual Debt To Equity
-1.90
-3.71-204.97%
December 31, 2022
Summary
- As of February 20, 2025, SRNE annual debt to equity ratio is -1.90, with the most recent change of -3.71 (-204.97%) on December 31, 2022.
- During the last 3 years, SRNE annual debt to equity has fallen by -4.89 (-163.55%).
- SRNE annual debt to equity is now -163.55% below its all-time high of 2.99, reached on December 31, 2019.
Performance
SRNE Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
-0.69
-0.12-21.05%
June 30, 2023
Summary
- As of February 20, 2025, SRNE quarterly debt to equity ratio is -0.69, with the most recent change of -0.12 (-21.05%) on June 30, 2023.
- Over the past year, SRNE quarterly debt to equity has dropped by -0.12 (-21.05%).
- SRNE quarterly debt to equity is now -112.17% below its all-time high of 5.67, reached on September 30, 2019.
Performance
SRNE Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
SRNE Debt To Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -205.0% | -21.1% |
3 y3 years | -163.6% | -21.1% |
5 y5 years | -6433.3% | -21.1% |
SRNE Debt To Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -205.0% | at low | -138.1% | +63.7% |
5 y | 5-year | -163.6% | at low | -123.1% | +63.7% |
alltime | all time | -163.6% | at low | -112.2% | +63.7% |
Sorrento Therapeutics Debt To Equity History
Date | Annual | Quarterly |
---|---|---|
Jun 2023 | - | -0.69(+21.1%) |
Mar 2023 | - | -0.57(-70.0%) |
Dec 2022 | -1.90(-205.0%) | -1.90(-451.9%) |
Sep 2022 | - | 0.54(-33.3%) |
Jun 2022 | - | 0.81(+19.1%) |
Mar 2022 | - | 0.68(-62.4%) |
Dec 2021 | 1.81(+158.6%) | 1.81(+115.5%) |
Sep 2021 | - | 0.84(+40.0%) |
Jun 2021 | - | 0.60(+36.4%) |
Mar 2021 | - | 0.44(-37.1%) |
Dec 2020 | 0.70(-76.6%) | 0.70(-14.6%) |
Sep 2020 | - | 0.82(-32.2%) |
Jun 2020 | - | 1.21(-38.6%) |
Mar 2020 | - | 1.97(-34.1%) |
Dec 2019 | 2.99(+169.4%) | 2.99(-47.3%) |
Sep 2019 | - | 5.67(+85.3%) |
Jun 2019 | - | 3.06(+69.1%) |
Mar 2019 | - | 1.81(+63.1%) |
Dec 2018 | 1.11(+3600.0%) | 1.11(+42.3%) |
Sep 2018 | - | 0.78(+1014.3%) |
Jun 2018 | - | 0.07(+133.3%) |
Mar 2018 | - | 0.03(0.0%) |
Dec 2017 | 0.03(-94.9%) | 0.03(-85.7%) |
Sep 2017 | - | 0.21(-27.6%) |
Jun 2017 | - | 0.29(-35.6%) |
Mar 2017 | - | 0.45(-23.7%) |
Dec 2016 | 0.59(+883.3%) | 0.59(+742.9%) |
Sep 2016 | - | 0.07(+40.0%) |
Jun 2016 | - | 0.05(-44.4%) |
Mar 2016 | - | 0.09(+50.0%) |
Dec 2015 | 0.06(-45.5%) | 0.06(-14.3%) |
Sep 2015 | - | 0.07(-46.2%) |
Jun 2015 | - | 0.13(+8.3%) |
Mar 2015 | - | 0.12(+9.1%) |
Dec 2014 | 0.11(+57.1%) | 0.11(-35.3%) |
Sep 2014 | - | 0.17(+13.3%) |
Jun 2014 | - | 0.15(-25.0%) |
Mar 2014 | - | 0.20(+185.7%) |
Dec 2013 | 0.07 | 0.07(-56.3%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2013 | - | 0.16(+14.3%) |
Jun 2013 | - | 0.14(+75.0%) |
Mar 2013 | - | 0.08(>+9900.0%) |
Dec 2012 | 0.00(0.0%) | 0.00(0.0%) |
Sep 2012 | - | 0.00(0.0%) |
Jun 2012 | - | 0.00(0.0%) |
Mar 2012 | - | 0.00(0.0%) |
Dec 2011 | 0.00(0.0%) | 0.00(0.0%) |
Sep 2011 | - | 0.00(0.0%) |
Jun 2011 | - | 0.00(0.0%) |
Mar 2011 | - | 0.00(0.0%) |
Dec 2010 | 0.00(0.0%) | 0.00(0.0%) |
Sep 2010 | - | 0.00(0.0%) |
Jun 2010 | - | 0.00(0.0%) |
Mar 2010 | - | 0.00(0.0%) |
Dec 2009 | 0.00(0.0%) | 0.00(0.0%) |
Sep 2009 | - | 0.00(0.0%) |
Jun 2009 | - | 0.00(0.0%) |
Mar 2009 | - | 0.00(0.0%) |
Dec 2008 | 0.00(0.0%) | 0.00(0.0%) |
Sep 2008 | - | 0.00(0.0%) |
Mar 2008 | - | 0.00(0.0%) |
Dec 2007 | 0.00(0.0%) | 0.00(0.0%) |
Sep 2007 | - | 0.00(0.0%) |
Jun 2007 | - | 0.00(0.0%) |
Mar 2007 | - | 0.00(0.0%) |
Dec 2006 | 0.00(0.0%) | 0.00(0.0%) |
Sep 2006 | - | 0.00(0.0%) |
Jun 2006 | - | 0.00(0.0%) |
Mar 2006 | - | 0.00(0.0%) |
Dec 2005 | 0.00(-100.0%) | 0.00(-100.0%) |
Sep 2005 | - | -0.03(0.0%) |
Jun 2005 | - | -0.03(0.0%) |
Mar 2005 | - | -0.03(0.0%) |
Dec 2004 | -0.03(0.0%) | -0.03(0.0%) |
Sep 2004 | - | -0.03(0.0%) |
Jun 2004 | - | -0.03(0.0%) |
Mar 2004 | - | -0.03 |
Dec 2003 | -0.03 | - |
FAQ
- What is Sorrento Therapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for Sorrento Therapeutics?
- What is Sorrento Therapeutics annual debt to equity year-on-year change?
- What is Sorrento Therapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly debt to equity year-on-year change?
What is Sorrento Therapeutics annual debt to equity ratio?
The current annual debt to equity of SRNE is -1.90
What is the all time high annual debt to equity for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual debt to equity ratio is 2.99
What is Sorrento Therapeutics annual debt to equity year-on-year change?
Over the past year, SRNE annual debt to equity ratio has changed by -3.71 (-204.97%)
What is Sorrento Therapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of SRNE is -0.69
What is the all time high quarterly debt to equity for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly debt to equity ratio is 5.67
What is Sorrento Therapeutics quarterly debt to equity year-on-year change?
Over the past year, SRNE quarterly debt to equity ratio has changed by -0.12 (-21.05%)